Amoxicillin Drug Market
Amoxicillin Drug Market Study by Skin Infections, ENT, Stomach Infections, Lung Infections, Urinary Tract Infections, Pneumonia, Bronchitis, and Gonorrhea From 2024 to 2034
Analysis of Amoxicillin Drug Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Amoxicillin Drug Market Outlook (2024 to 2034)
The global amoxicillin drug market is currently valued at US$ 4.48 billion in 2024 and is forecasted to expand at a CAGR of 4% to reach US$ 6.64 billion by 2034.
Amoxicillin comes under widely prescribed antibiotics globally. According to some reports in 2023, around 18.26% of all antibiotic prescriptions in outpatient settings were for amoxicillin with nearly 270 million total antibiotic prescriptions, this accounts for nearly 49 million prescriptions for amoxicillin in the United States alone. This usage is further projected to keep escalating worldwide with varying volumes by region.
In Europe, Asia Pacific, and America, it is the leading antibiotic, primarily used for bacterial infections, such as respiratory tract infections, otitis media, and skin conditions.
Seeing these demands, several manufacturers have expanded their production volumes with China heading on top with 40% annual production, followed by India with 25%. More manufacturers for this reason are investing a hefty amount in the East Asia region to establish their production centers to keep themselves in the profit circle.
The demand for amoxicillin is also increasing due to more than average people facing respiratory issues, such as RSV, flu, and COVID-19. This surge in infection, especially among children is leading to a higher need for antibiotics, including amoxicillin, which is commonly prescribed for ears, throat, and respiratory infections.
In the United States, the FDA has identified a shortage of amoxicillin oral suspension particularly especially for pediatric patients. This is crucial for treating children, these shortages are going to work positively for manufacturers in China and India, making the market grow significantly in the East Asian region.
Major significant advancements are becoming obvious in this market; one significant advancement is the development of amoxicillin-clavulanate combinations, which help in inhibiting the beta-lactamase enzymes enhancing the overall effectiveness against a broader spectrum of infections.
Several researchers are also putting their effort into investigating combining amoxicillin with other antimicrobial agents, such as beta-lactamase inhibitors to boost efficacy against multi-drug-resistant organisms. These innovations highlight all the ongoing efforts to ensure that amoxicillin remains an effective treatment option while also addressing the rising challenge of antibiotic resistance and improving patient access to the drug in high-demand periods.
| Report Attribute | Detail |
|---|---|
| Amoxicillin Drug Market Size (2024E) | US$ 4.48 Billion |
| Forecasted Market Value (2034F) | US$ 6.64 Billion |
| Global Market Growth Rate (2024 to 2034) | 4% CAGR |
| East Asia Market Value (2034F) | US$ 1.27 Billion |
| North America Market Growth Rate (2034F) | 3.9% |
| Oral Segment Value (2034F) | US$ 5.29 Billion |
| Japan Market Value (2034F) | US$ 298.48 Million |
| Key Companies Profiled | Novartis; Dr. Reddy Laboratories; JAMP Pharma Corporation; Northwind Pharmaceuticals; Profecient Ex LP; Sun Pharmaceuticals |
Amoxicillin drugs is a form of generic drugs of Amoxil branded drug commonly used in the treatment of bacterial infections. The amoxicillin drugs fall under the drug class of β-lactam antibiotics. The increasing number of bacterial infections around the world, especially, in developing and low-income countries is one of the reasons for the growing demand for amoxicillin drugs and hence, boosting the growth of the amoxicillin drug market.
In the 1980s, the Food and Drug Administration (FDA) first approved amoxicillin drug.
The surveillance released by the World Health Organization (WHO) showed that in high- and low-income countries increasing levels of antibiotic resistance to several serious bacterial infections. The Global Antimicrobial Surveillance System (GLASS) showed the occurrence of widespread antibiotic resistance among 500,000 people with a high risk of bacterial infections across 22 countries.
However, amoxicillin drugs are suggested not to be taken if the patients are allergic to any kind of penicillin antibiotic or amoxicillin. Some people do not know if they have infections or not, due to which patients go through some serious complications. This restrains the growth of the amoxicillin drug market.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Amoxicillin Drugs: Market Dynamics
Today, there is a variety of branded and generic versions of amoxicillin drugs are available in the market. Several drug manufacturers are manufacturing amoxicillin drugs and distributing them in the market.
The amoxicillin drugs are also used a combination with other drugs used to treat a bacterial infection, such as triple therapy (amoxicillin/clarithromycin/lansoprazole) and dual therapy (amoxicillin/lansoprazole). These dual and triple therapies are under clinical trials.
The rising number of clinical trials to check the efficacy and effects of combination drugs with amoxicillin drugs is expected to drive the growth of the amoxicillin drug market in the forecast period. However, the most common adverse effects observed in clinical trials on combination drugs are diarrhea, vomiting, rash, and nausea.
This delays the marketing of combination drugs in the market and hampers the growth of the amoxicillin drug market in the forecast period.
Amoxicillin Drug Market: Overview
According to the World Health Organization (WHO), the most common resistant bacteria reported were Escherichia coli, Staphylococcus aureus, Streptococcus pneumonia, Salmonella spp., and Klebsiella pneumonia. Moreover, several forms are available for amoxicillin drugs in the market, such as tablets, capsules, suspensions, powder, and syrup.
For people who find difficulty in taking tablets or capsules, suspension, syrup, or powdered form amoxicillin drugs are used. Suspension amoxicillin drugs are widely used by pediatric patients. Amoxicillin drugs are available in a wide variety of distribution channels. These factors are expected to boost the growth of the amoxicillin drug market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Amoxicillin Drug Market: Region-wise Outlook
North America is expected to show the highest revenue growth due to high investment in clinical trials and R&D spending, followed by Europe. The amoxicillin drug market in the Asia-Pacific region is expected to show high CAGR growth due to the large patient pool who are at high risk of bacterial infections because of poor sanitation, unsafe drinking water, and high population.
Latin America and the Middle East & Africa are also at high risk of bacterial infections due unavailability of safe water.
Amoxicillin Drug Market: Key Players
Some of the key players present in the global amoxicillin drug market are JAMP Pharma Corporation, Novartis, Dr. Reddy's Laboratories, Sun Pharmaceuticals, Proficient Rx LP., Sanis Health Inc., Nucare Pharmaceuticals, Inc., Northwind Pharmaceuticals, A-S Medication Solutions, Bryant ranch prepack and others.
The report covers an exhaustive analysis on :
- Market Segments
- Market Dynamics
- Market Size
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
The regional analysis includes :
- North America (United States, Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, United Kingdom, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- The Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Japan
- The Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of several market factors on market segments and geographies.
Report Highlights :
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Segmentation of Amoxicillin Drug Market Research
-
By Infection Type :
- Skin Infection
- ENT
- Stomach Infection
- Lungs Infection
- Urinary Tract Infection
- Pneumonia
- Bronchitis
- Gonorrhea
-
By Route of Administration :
- Oral
- Intravenous
-
By Form :
- Tablets
- Capsules
- Suspensions
- Syrups
- Powder
-
By Distribution Channel :
- Hospitals Pharmacies
- Drug Stores
- Retail Stores
- Online Pharmacies
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Infection Type
- 6.2. Route Of Administration
- 6.3. Form
- 6.4. Distribution Channels
- 7. Global Market Analysis and Forecast, By Infection Type
- 7.1. Skin Infections
- 7.2. ENT (Ear, Nose & Throat) Infections
- 7.3. Stomach Infections
- 7.4. Lungs Infections
- 7.5. Urinary Tract Infections (UTI)
- 7.6. Pneumonia
- 7.7. Bronchitis
- 7.8. Gonorrhea
- 8. Global Market Analysis and Forecast, By Route Of Administration
- 8.1. Oral
- 8.2. Intravenous
- 9. Global Market Analysis and Forecast, By Form
- 9.1. Tablets
- 9.2. Capsule
- 9.3. Suspensions
- 9.4. Syrup
- 9.5. Powder
- 10. Global Market Analysis and Forecast, By Distribution Channels
- 10.1. Hospitals Pharmacies
- 10.2. Drug Stores
- 10.3. Retail Stores
- 10.4. Online Pharmacies
- 11. Global Market Analysis and Forecast, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Western Europe
- 11.4. Eastern Europe
- 11.5. Asia Pacific
- 11.6. East Asia
- 11.7. MEA
- 12. North America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 14. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 16. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 17. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 18. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 19. Sales Forecast by Infection Type, Route Of Administration, Form, and Distribution Channels for 30 Countries
- 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 21. Company Profile
- 21.1. JAMP Pharma Corporation
- 21.2. Novartis
- 21.3. Dr. Reddy's Laboratories
- 21.4. Sun Pharmaceuticals
- 21.5. Proficient Rx LP
- 21.6. Sanis Health Inc
- 21.7. Nucare Pharmaceuticals, Inc.
- 21.8. Northwind Pharmaceuticals
- 21.9. A-S Medication Solutions
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Infection Type
Table 3: Global Market US$ Mn Forecast by Route Of Administration
Table 4: Global Market US$ Mn Forecast by Form
Table 5: Global Market US$ Mn Forecast by Distribution Channels
Table 6: North America Market US$ Mn Forecast by Country
Table 7: North America Market US$ Mn Forecast by Infection Type
Table 8: North America Market US$ Mn Forecast by Route Of Administration
Table 9: North America Market US$ Mn Forecast by Form
Table 10: North America Market US$ Mn Forecast by Distribution Channels
Table 11: Latin America Market US$ Mn Forecast by Country
Table 12: Latin America Market US$ Mn Forecast by Infection Type
Table 13: Latin America Market US$ Mn Forecast by Route Of Administration
Table 14: Latin America Market US$ Mn Forecast by Form
Table 15: Latin America Market US$ Mn Forecast by Distribution Channels
Table 16: Western Europe Market US$ Mn Forecast by Country
Table 17: Western Europe Market US$ Mn Forecast by Infection Type
Table 18: Western Europe Market US$ Mn Forecast by Route Of Administration
Table 19: Western Europe Market US$ Mn Forecast by Form
Table 20: Western Europe Market US$ Mn Forecast by Distribution Channels
Table 21: Eastern Europe Market US$ Mn Forecast by Country
Table 22: Eastern Europe Market US$ Mn Forecast by Infection Type
Table 23: Eastern Europe Market US$ Mn Forecast by Route Of Administration
Table 24: Eastern Europe Market US$ Mn Forecast by Form
Table 25: Eastern Europe Market US$ Mn Forecast by Distribution Channels
Table 26: Asia Pacific Market US$ Mn Forecast by Country
Table 27: Asia Pacific Market US$ Mn Forecast by Infection Type
Table 28: Asia Pacific Market US$ Mn Forecast by Route Of Administration
Table 29: Asia Pacific Market US$ Mn Forecast by Form
Table 30: Asia Pacific Market US$ Mn Forecast by Distribution Channels
Table 31: East Asia Market US$ Mn Forecast by Country
Table 32: East Asia Market US$ Mn Forecast by Infection Type
Table 33: East Asia Market US$ Mn Forecast by Route Of Administration
Table 34: East Asia Market US$ Mn Forecast by Form
Table 35: East Asia Market US$ Mn Forecast by Distribution Channels
Table 36: MEA Market US$ Mn Forecast by Country
Table 37: MEA Market US$ Mn Forecast by Infection Type
Table 38: MEA Market US$ Mn Forecast by Route Of Administration
Table 39: MEA Market US$ Mn Forecast by Form
Table 40: MEA Market US$ Mn Forecast by Distribution Channels
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type
Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form
Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type
Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form
Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 26: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type
Figure 27: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 28: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form
Figure 29: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 30: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 31: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type
Figure 32: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 33: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form
Figure 34: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 35: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Infection Type
Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Form
Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the key trend in the amoxicillin drug market?
Rising Number of clinical trials to check the efficacy drives amoxicillin drug market growth.
Which route of administration drives the most demand for the amoxicillin drug market?
he intravenous route of administration is contributing to market prospects.
Amoxicillin Drug Market